XBiotech (NASDAQ:XBIT) Stock, Quote.Headers.trade-ideas

XBiotech

XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.

Cancer-Image by PDPics from Pixabay-

Biotech

Equities

News

Health Care

Movers

Trading Ideas

General

XBIT

XBiotech reveals results from its Phase 1/Phase 2 1-BETTER Study for advanced pancreatic cancer, highlighting the safety and tolerability of Natrunix with the ONIVYDE + 5-Fluorouracil + Leucovorin regimen.

What&#39;s Going On With Small-Cap Cancer Focused XBiotech On Tuesday?

Penny Stocks

Small Cap

Pre-Market Outlook

Markets

AGYS

ANGH

ARDX

ASPI

CISO

CRVS

DOCS

EFSH

Sunrise New Energy Co., Ltd - Ordinary Shares

EPOW

EVGO

GSIT

HESM

ICPT

IMPL

INTA

JCSE

KBNT

KEYS

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

MDVL

MGOL

Airspan Networks Holdings Inc. Common Stock

MIMO

MOTS

NCPL

NWLI

PBTS

PIII

PUMP

SDIG

SFWL

SMFL

SVRE

TCJH

TPHS

WETG

Why Doximity Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Wednesday&#39;s Mid-Day Session

Earnings

Eurozone

Commodities

Global

Intraday Update

PRPL

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 100 points on Wednesday.

Following the market opening Wednesday, the Dow traded up 0.37% to 33,135.37 while the NASDAQ rose 0.39% to 12,391.68. The S&amp;P 500, also rose, gaining, 0.45% to 4,128.33.

Dow Jumps Over 100 Points; US Housing Starts Rise In April

XBiotech Inc

Press Releases

XBiotech Results from Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treatment for Advanced Pancreatic Cancer

Junior Biotech Utilizes AI To Shorten Drug Discovery Timelines, Ultimately Saving Lives

XBiotech Pauses Rheumatology program

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc. - XBIT

XBIT Investors Have Opportunity to Join XBiotech Inc. Fraud Investigation with the Schall Law Firm

Legal

Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating XBiotech for potential violations of securities laws

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc. - XBIT

AMGEN

BMRN

KTRA

RHHBY

TSX:RKV

TSXV:RKV

Adagene Inc. - ADS, each representing 1.25 ordinary shares

Adagene

Cibus

Coherus Oncology

Climb Bio

Coya Therapeutics

Elutia

Forte Biosciences

HilleVax

IGM Biosciences

Immuneering Corporation - Class A Common Stock

Immuneering

Immunic

Inovio Pharmaceuticals, Inc. - Common Stock

Inovio Pharmaceuticals

IO Biotech

Jasper Therapeutics, Inc. - Class A Common Stock

Jasper Therapeutics

OncoCyte

OKYO Pharma

Outlook Therapeutics, Inc. - Common Stock

Outlook Therapeutics

PDS Biotechnology Corporation - Common Stock

PDS Biotechnology

Pyxis Oncology

Senti Biosciences

Surrozen

Sutro Biopharma

TScan Therapeutics

Unicycive Therapeutics, Inc. - Common Stock

Unicycive Therapeutics

Zura Bio Limited - Class A Ordinary shares

Zura Bio

Comments

XBiotech

XBiotech (NASDAQ:XBIT) Stock, Quote.Headers.trade-ideas

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell